China Pharma HoldingsCPHI
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 5 institutions reported holding China Pharma Holdings Inc. (CPHI) in their 13F filings, unchanged from Q2 2025. 2 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($59K), UBS Group AG ($37K) and Renaissance Technologies ($21K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- China Pharma Holdings Inc.
- CUSIP
- 16941T401
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $21K |
| Exits | 2 | $43K |
All 13F filers, Q2 2025 → Q3 2025: 18,014 shares bought and 76,423 shares sold, net −58,409 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Citadel Advisors | 0.00% | Add +31.9% | 30,426 | $59K |
| UBS Group AG | 0.00% | Reduce -73.1% | 19,191 | $37K |
| Renaissance Technologies | 0.00% | New | 10,618 | $21K |
| JPMorgan Chase & Co. | 0.00% | New | 40 | $78 |
| Danske Bank A/S | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CPHI's weight in each manager's 13F, not the share of China Pharma Holdings Inc. the manager owns.